Use of antimesothelial cell antibody and computer assisted quantitative analysis for distinguishing between reactive and neoplastic serosal tissues
- PMID: 3323251
- PMCID: PMC1141278
- DOI: 10.1136/jcp.40.12.1428
Use of antimesothelial cell antibody and computer assisted quantitative analysis for distinguishing between reactive and neoplastic serosal tissues
Abstract
Nine malignant mesotheliomas and 12 specimens of benign reactive mesothelial hyperplasia were examined using a specific antimesothelial cell antibody. Immunostaining intensity was subsequently estimated by means of image analysis. The mean and standard deviation of integrated optical density in the malignant mesotheliomas differed significantly from those in the mesothelial hyperplasias. In all mesotheliomas but one the integrated optical density was greater than in reactive mesothelial hyperplasia. No significant difference in optical density was observed between the two groups; the standard deviation was significantly higher in the reactive lesions. This technique may be adopted to complement the traditional morphological assessment of primary lesions of the serosal cavities.
Similar articles
-
Verification of the histologic diagnosis of malignant mesothelioma in relation to the binding of an antimesothelial cell antibody.Cancer. 1989 Apr 1;63(7):1331-6. doi: 10.1002/1097-0142(19890401)63:7<1331::aid-cncr2820630718>3.0.co;2-3. Cancer. 1989. PMID: 2646006
-
The differential diagnosis of epithelial-type mesothelioma from adenocarcinoma and reactive mesothelial proliferation.J Pathol. 1991 Apr;163(4):299-305. doi: 10.1002/path.1711630406. J Pathol. 1991. PMID: 2033489
-
Newly marketed tissue markers for malignant mesothelioma: immunoreactivity of rabbit AMAD-2 antiserum compared with monoclonal antibody HBME-1 and a review of the literature on so-called antimesothelioma antibodies.Hum Pathol. 1997 Aug;28(8):929-37. doi: 10.1016/s0046-8177(97)90008-3. Hum Pathol. 1997. PMID: 9269829
-
Epithelioid lesions of the serosa.Arch Pathol Lab Med. 2012 Mar;136(3):241-52. doi: 10.5858/arpa.2010-0216-RA. Arch Pathol Lab Med. 2012. PMID: 22372900 Review.
-
Pathology of malignant mesothelioma.Lung Cancer. 2004 Aug;45 Suppl 1:S35-6. doi: 10.1016/j.lungcan.2004.04.006. Lung Cancer. 2004. PMID: 15261431 Review.
Cited by
-
ME1. A monoclonal antibody that distinguishes epithelial-type malignant mesothelioma from pulmonary adenocarcinoma and extrapulmonary malignancies.Am J Pathol. 1990 Feb;136(2):421-8. Am J Pathol. 1990. PMID: 2305835 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical